Integra LifeSciences Holdings (IART)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -18,236 | -11,919 | 27,052 | 46,061 | 81,069 | 116,419 | 156,606 | 204,357 | 213,894 | 201,473 | 193,465 | 186,714 | 214,677 | 201,806 | 192,529 | 149,356 | 93,520 | 81,011 | 11,991 | 46,723 |
| Revenue (ttm) | US$ in thousands | 1,596,615 | 1,533,335 | 1,521,985 | 1,473,066 | 1,486,381 | 1,488,778 | 1,493,656 | 1,509,844 | 1,505,291 | 1,519,581 | 1,519,648 | 1,510,233 | 1,535,982 | 1,529,270 | 1,504,267 | 1,371,086 | 1,317,264 | 1,323,744 | 1,339,441 | 1,466,719 |
| Pretax margin | -1.14% | -0.78% | 1.78% | 3.13% | 5.45% | 7.82% | 10.48% | 13.53% | 14.21% | 13.26% | 12.73% | 12.36% | 13.98% | 13.20% | 12.80% | 10.89% | 7.10% | 6.12% | 0.90% | 3.19% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-18,236K ÷ $1,596,615K
= -1.14%
The pretax margin of Integra LifeSciences Holdings has shown fluctuating trends over the past few years. It started at 3.19% in March 2020 and dipped to 0.90% in June 2020. However, there was a significant improvement in the pretax margin, reaching 7.10% by December 2020.
Throughout 2021, the pretax margin continued to rise steadily, reaching its peak of 13.98% by the end of December 2021. Despite a slight dip in the first quarter of 2022, the pretax margin remained relatively strong, ranging between 10.48% and 14.21% up to the end of December 2022.
However, there was a noticeable decline in the pretax margin in the following quarters of 2023 and 2024, dropping to as low as -1.14% in December 2024. This downward trend indicates potential challenges in maintaining profitability and efficiency in generating earnings before taxes.
Overall, while the company demonstrated periods of strong profitability with double-digit pretax margins, the recent decline raises concerns about its ability to sustain competitive margins and may require further analysis and strategic adjustments to improve financial performance.
Peer comparison
Dec 31, 2024